α-Aminoboronic acid moieties in boro dipeptides modulate proteasome subunit selectivity and provide access to compounds with potent anticancer and anti-inflammatory activity

Strašek Benedik, Nika (avtor), Šterman, Andrej (avtor), Smrdel, Lara (avtor), Pajk, Stane (avtor), Gobec, Stanislav (avtor), Časar, Zdenko (avtor), Gobec, Martina (avtor), Sosič, Izidor (avtor)

Proteasomes regulate cellular protein homeostasis and are key targets in treating cancer, inflammation, and autoimmune diseases. The two main forms, the constitutive proteasome and immunoproteasome, each contain three catalytically active subunits with distinct substrate specificities. The first approved proteasome inhibitor, bortezomib, is nonselective and causes dose-limiting toxicity. Herein, we report dipeptide boronic acids with varying P1 residues, prepared using our recently developed method for α-aminoboronic acids formation. Most compounds inhibited various immuno/proteasome subunits in the low nanomolar range, displaying inhibition profiles distinct from bortezomib, ranging from β5i/β1i-selective to β5c/β5i-directed inhibitors. Although their cytotoxicity to cancer cells was not improved compared to bortezomib, selected compounds proved less toxic to noncancer cells and with anti-inflammatory activity comparable to that of zetomipzomib (KZR-616). The presented boro dipeptides with tailored P1 residues provide a basis for designing subunit-selective compounds with boronic acid as the warhead and optimized P2 and/or P3 positions.

• Jezik: Angleški jezik
• Ključne besede: proteasomes, homeostasis, cellular proteins, anticancer activity, anti-inflammatory activities, cells, inhibition, inhibitors, peptides, proteins, screening assays
• Vrsta gradiva: Članek v reviji
• Tipologija: 1.01 - Izvirni znanstveni članek
• Organizacija: FFA - Fakulteta za farmacijo
• Status publikacije: Objavljeno
• Različica publikacije: Objavljena publikacija
• Leto izida: 2025
• Št. strani: Str. 26405−26417
• Številčenje: Vol. 68, iss. 24
• PID: 20.500.12556/RUL-177836
• UDK: 543.2/.9
• ISSN pri članku: 1520-4804
• DOI: 10.1021/acs.jmedchem.5c02548
• COBISS.SI-ID: 260217091
• Datum objave v RUL: 09.01.2026

Gradivo je del revije

• Naslov: Journal of medicinal chemistry
• Skrajšan naslov: J. med. chem.
• Založnik: American Chemical Society
• ISSN: 1520-4804
• COBISS.SI-ID: 512806681

Licence

• Licenca: CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
• Povezava: http://creativecommons.org/licenses/by/4.0/deed.sl
• Opis: To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

• Jezik: Slovenski jezik
• Ključne besede: proteasomi, homeostaza, celične beljakovine, antikancerogeno delovanje, protivnetno delovanje, farmacevtska kemija, citologija, celična fiziologija, antionkogeni, protivnetna zdravila